EmPOWER M.E. 2023: Navigating the World with Energy Limiting Disabilities
Hosting EmPOWER M.E. during Advocacy Week each year is one of our favorite ways to connect with our community after a long week of congressional meetings. This year, our Lived […]
Guest Blog: How People With Long Covid Can Qualify For Social Security Disability Benefits
Elizabeth Van Arsdall is a recent graduate of Colby College living in Boston and a native of Washington, D.C. Like so many others, Elizabeth has seen firsthand the effects of Covid […]
Ask Congress to CARE!
We’re excited to announce our House and Senate asks for Solve M.E.’s Advocacy Week 2023! The two pieces of legislation are companion pieces to one another — we will be […]
Solve M.E. CEO Oved Amitay On Potential EBV Vaccine Candidate
Originally published by Solve M.E. CEO Oved Amitay in a LinkedIn post. Very encouraging to learn today that top experts from OPKO Health, Inc. and ModeX Therapeutics Inc team up with Merck to develop Epstein-BarrVirus Vaccine Candidate. […]
CDC Responds to Solve M.E. Comments on Draft Review of Diagnosis and Treatment of ME/CFS
In 2018, the Centers for Disease Control and Prevention (CDC) announced it was soliciting bids to create evidence-based treatment guidelines for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In 2019, the CDC […]
Kevin Timms, PhD, Joins Ramsay Researchers Class of 2022!
We’re excited to share that Kevin Timms, PhD, is joining our Ramsay Class of 2022! Solve’s Ramsay Research Grant Program attracts new scientists to the field of ME/CFS and Long […]
Watch now! “Long Covid: What Will it Take to Accelerate Therapeutic Progress?”
Solve M.E. and BIO co-hosted a timely and informative event examining the emerging research in Long Covid and the existing body of data in other post-infection diseases such as ME/CFS. […]
FDA Patient-Focused Drug Development Public Meeting for Long Covid
The US Food and Drug Administration (FDA) is hosting a virtual public meeting on Patient-Focused Drug Development for Long Covid on Tuesday, April 25th, 2023, from 10 a.m. to 4:00 p.m. […]
FDA to Host Patient-Focused Drug Development Public Meeting for Long Covid
The US Food and Drug Administration (FDA) is hosting a virtual public meeting on Patient-Focused Drug Development for Long Covid on Tuesday, April 25th, 2023, from 10 a.m. to 4:00 p.m. […]
Sen. Tim Kaine Shares His Long Covid Experience at Solve Event, Calls for More Research and Equitable Care
Solve recently co-hosted with BIO the event “Long Covid: What Will It Take to Accelerate Therapeutic Progress?,” convening stakeholders to advance research and development to diagnose and treat Long Covid, […]
New Studies Point to a Signature for ME/CFS: Will They Lead to Widely Used Diagnostic Tests?
By Oved Amitay, Solve M.E. President and CEO Three studies were published last week, describing incredibly intriguing data, each pointing to specific biomarkers that can help to identify people with […]
New Findings Alert! NIH-Funded Studies Link Altered Gut Microbes to ME/CFS
Recently released papers with findings from two National Institutes of Health-funded studies by the Center for Solutions for ME/CFS & The Jackson Laboratory indicate that microbiome changes may be a […]
